AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during Glomerulonephritis

Area of Science:

• Immunology
• Nephrology
• Cell Biology

Background:

• Absent in melanoma-2 (AIM2) is an innate immune sensor with known inflammasome-dependent and -independent functions.
• AIM2's role in kidney physiology and glomerular disease remains incompletely understood.
• AIM2 is expressed in human glomeruli, localizing to podocytes in normal tissue.

Purpose of the Study:

• To investigate the localization and function of AIM2 in the kidney, particularly in the context of glomerulonephritis.
• To determine AIM2's role in regulating inflammation and cellular proliferation within the glomerulus.

Main Methods:

• Immunofluorescence staining of human kidney biopsies to assess AIM2 localization.
• Analysis of Aim2 knockout (Aim2^-/-) mice in a nephrotoxic serum (NTS)-induced glomerulonephritis model.
• Gene expression analysis (WT1 and podocyte-specific genes) and cell proliferation assays (outgrowth assays).

Main Results:

• In glomerulonephritis patients, AIM2 expression increased in activated parietal epithelial cells within glomerular crescents.
• Aim2^-/- mice exhibited exacerbated glomerular crescent formation, tubular injury, inflammation, and proteinuria in the NTS model.
• AIM2 deficiency led to dysregulated cellular proliferation and increased CD44+ parietal epithelial cells, independent of inflammasome activation.
• The AIM2-like receptor (ALR) locus was necessary for the inflammatory phenotype but dispensable for AIM2's effect on epithelial cell proliferation.

Conclusions:

• AIM2 plays a noncanonical role in suppressing inflammation and epithelial cell proliferation in glomerulonephritis.
• AIM2 deficiency exacerbates kidney injury by promoting inflammation and uncontrolled cell growth.
• These findings identify AIM2 as a potential therapeutic target for glomerular diseases.